Drug Profile
Saredutant
Alternative Names: SR 48968Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator sanofi-aventis
- Class Antidepressants; Benzamides; Piperidines
- Mechanism of Action Neurokinin 2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Generalised anxiety disorder; Inflammatory bowel diseases; Irritable bowel syndrome; Major depressive disorder; Pain
Most Recent Events
- 29 Apr 2009 Discontinued - Phase-III for Depression in Argentina (PO)
- 29 Apr 2009 Discontinued - Phase-III for Depression in Chile (PO)
- 29 Apr 2009 Discontinued - Phase-III for Depression in Croatia (PO)